Conclusion
Through the extensive work put into this study, an adherence assessment
tool for asthmatic patients was developed. The AAMQ-13 has a high
internal validity, good criterion validity, and strong construct
validity. All of these findings suggest that the AAMQ-13 is a promising
tool for future use as an adherence assessment questionnaire in
asthmatic patients. From a clinical perspective, uncontrolled asthma
requires long-term adherence to the medications and the treatment plan;
thus, a short, brief, feasible, reliable, and valid measure of patient
adherence is needed which can be used in all medical practice
conditions. Moreover, most of the questionnaires available up to date
can only identify non-adherent patients. The AAMQ-13 is the only
questionnaire that was specifically designed and validated in the Middle
East to assess asthmatic patient adherence to their medications and
predict patients’ patterns of non-adherence. It can also predict other
important outcomes; as a significant correlation was found between the
AAMQ-13 and ACT, and PHBS questionnaires, so it can give an indication
whether the patient’s asthma symptoms are controlled and it gives an
insight about the patient’s lifestyle.